The immunohistochemical staining revealed that all the NHB tissues displayed no or extremely low levels of UBE2C protein expression (IRS ≦2, 27/27); however, 63% of the glioma tissues (97/154) exhibited strong UBE2C immunoreactivity (IRS ≧4). The gene discussed is UBE2C; the disease is glioma.